Nelson Scott M, Fleming Richard
Reproductive and Maternal Medicine, University of Glasgow, Glasgow, UK.
Curr Opin Obstet Gynecol. 2007 Aug;19(4):384-9. doi: 10.1097/GCO.0b013e32825e1d70.
To examine the impact of obesity and potential intervention upon human reproduction in the domain of fertility, fertility treatment, pregnancy and its complications.
The prevalence of obesity in women of reproductive age continues to increase, with recent recognition that visceral obesity is associated with greater metabolic disturbances and reduced fecundity, even in ovulating women. Although the efficacy of infertility treatment is reduced by obesity, this effect is not profound and indeed the argument for weight reduction in young women is better serviced by the obesity-dependent increases in perinatal and maternal risks during pregnancy and potential modification of long-term health. Although lifestyle modification alone can induce significant metabolic improvement, resumption of ovulation and reduction of perinatal risks, greater weight loss, and therefore greater potential benefit, can be achieved in combination with pharmacological agents or bariatric surgery.
Obesity in women has a broad, negative impact upon human reproduction. Specific risks through pregnancy are real and may be addressed by lifestyle modification leading to weight loss and improved insulin sensitivity. Obese women undergoing fertility treatment should be advised of the increased and absolute increased risks they are undertaking, and fertility centres should adopt appropriate strategies.
探讨肥胖及其潜在干预措施对人类生殖在生育力、生育治疗、妊娠及其并发症等方面的影响。
育龄女性肥胖率持续上升,近期研究认识到,即使对于排卵女性,内脏肥胖也与更严重的代谢紊乱及生育力降低相关。尽管肥胖会降低不孕治疗的疗效,但这种影响并不显著,事实上,年轻女性减重的理由更在于肥胖导致孕期围产期及母体风险增加以及对长期健康的潜在影响。尽管单纯的生活方式改变可显著改善代谢、恢复排卵并降低围产期风险,但联合使用药物或进行减肥手术可实现更大程度的体重减轻,从而带来更大的潜在益处。
女性肥胖对人类生殖有广泛的负面影响。孕期的特定风险真实存在,可通过导致体重减轻和改善胰岛素敏感性的生活方式改变来应对。应告知接受生育治疗的肥胖女性她们所面临的风险增加及绝对风险增加的情况,生育中心应采取适当策略。